Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro

by Chengle Zhuang, Changshui Zhuang, Qun Zhou, Xueting Huang, Yaoting Gui, Yongqing Lai, Shangqi Yang
Published 2021-03-01

Synthetic regulatory RNAs selectively suppress the progression of bladder cancer

by Chengle Zhuang, Xinbo Huang, Changshui Zhuang, Xiaomin Luo, Xiaowei Zhang, Zhiming Cai, Yaoting Gui
Published 2017-10-01

Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling

by Changshui Zhuang, Ying Liu, Shengqiang Fu, Chaobo Yuan, Jingwen Luo, Xueting Huang, Weifeng Yang, Wuwei Xie, Chengle Zhuang
Published 2021-09-01

Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling

by Changshui Zhuang, Ying Liu, Shengqiang Fu, Chaobo Yuan, Jingwen Luo, Xueting Huang, Weifeng Yang, Wuwei Xie, Chengle Zhuang
Published 2020-12-01

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

by Yawen Li, Jing Quan, Fangfang Chen, Xiang Pan, Changshui Zhuang, Tiefu Xiong, Chengle Zhuang, Jianfa Li, Xinbo Huang, Jing Ye, Fangting Zhang, Zeng Zhang, Yaoting Gui
Published 2019-03-01